Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by HuntNGatheron Mar 26, 2015 12:03pm
143 Views
Post# 23564509

RE:RE:Panel Presentation Tomorrow in NYC

RE:RE:Panel Presentation Tomorrow in NYC
I may be wrong but many of the presentations in the past were not as specific as this nor were they in NYC with an entire section of the conference dedicated to Wall Street and Immuno-Oncology. I dunno Noodley, I have shown signs of delusion in the past but it is better to be invited to participate and share information than it is to be putting up a poster in a giant trade show area. Uger actually gets to speak at this one. And there are not that many people on the expert side. Call me a foolish optimist. I still say we finish green for the day. You can call me crazy later. No offense will be taken. HnG
Bullboard Posts